Dare Bioscience, Inc. Operating Lease, Liability, Noncurrent
Dare Bioscience, Inc. (DARE) had Operating Lease, Liability, Noncurrent of $273.87 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Noncurrent $273.87K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $418.25K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $559.37K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $288.57K.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $273.87K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $418.25K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $559.37K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $288.57K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $448.21K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $603.29K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $754.38K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $897.79K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.04M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.17M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $935.74K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $23.33K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $57.13K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $90.35K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $194.59K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $823.95K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $913.11K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | |
| 2021-09-30 | $15.80K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $73.52K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $151.79K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $41.84K 10-Q · filed 2021-11-10 | $42.00K 10-K · filed 2021-03-30 |
| 2020-09-30 | $82.96K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $175.27K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $284.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $389.56K 10-Q · filed 2020-11-12 | |
| 2019-09-30 | $90.95K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $116.09K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $139.29K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $389.00K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |